Preventive Screening Hub

Early detection changes outcomes. This hub connects PatientGuide’s evidence-based screening guides — from cancer programs to cardiovascular and metabolic checks — into a single preventive health pathway.

Why Screening Matters

Most serious diseases begin silently. Heart disease, type 2 diabetes, bowel cancer, and cervical cancer can all be present for years before causing symptoms — and the window for effective treatment is widest before symptoms appear.

Organised screening programs exist because the evidence consistently shows that finding disease early saves lives:

Bowel cancer caught at an early stage has a five-year survival rate above 90%; advanced disease falls below 15%.
Cervical cancer is largely preventable through HPV vaccination and screening — countries with high participation have driven incidence toward near-elimination.
Breast cancer detected by routine mammography is more likely to be localised, with better treatment options and survival outcomes.
Blood pressure and cholesterol, when identified and treated early, substantially reduce the risk of first heart attack and stroke.

Balancing Benefits and Harms

Screening is not without tradeoffs. Understanding both sides helps inform decisions:

False positives — a test suggests disease when none exists, leading to anxiety and follow-up procedures
Overdiagnosis — detecting slow-growing conditions that might never cause harm, resulting in treatment with no benefit
False negatives — a test misses existing disease, creating false reassurance

No screening test is perfect. Most programs are designed so that benefits outweigh harms across the population — but individual circumstances vary. Shared decision-making with your clinician is the right approach, particularly for tests like PSA where the evidence is more nuanced.

For a deeper primer on how to interpret tests and results, see Testing and Screening — Guide Hub.

Cancer Screening

Cervical Cancer

Cervical cancer is almost entirely preventable. HPV vaccination and regular screening together have driven incidence toward near-elimination in countries with high participation.

Cervical Cancer Screening Explained: HPV Testing and Self-Collection — how the national programme works, what HPV testing involves, and the option of at-home self-collection
Cervical Screening by Age: What Tests You Need and When — age-based guidance from early adulthood through to post-menopause
HPV Testing vs Pap Smear: What’s the Difference? — how the transition from cytology to HPV-first screening changed outcomes

Who should screen: People with a cervix, typically from age 25 (varies by country). Intervals vary but most HPV-based programs recommend 5-yearly testing in people with a normal result.

Breast Cancer

Mammography is the only screening modality with demonstrated reduction in breast cancer mortality in randomised trials.

Mammography and Breast Cancer Screening: What You Need to Know — how mammography works, BI-RADS results, dense breast considerations, and what happens after a recall

Who should screen: Women aged 50–74 in most national programs; many guidelines support starting from 40 with shared decision-making. Women with high genetic risk (BRCA1/2) need earlier, more intensive surveillance.

Bowel Cancer

Bowel cancer is one of the most common cancers in high-income countries and one of the most preventable through screening.

Bowel Cancer Screening Explained — who should be screened, how FIT and colonoscopy work, intervals, and positive result pathways
Bowel Cancer Screening — Early Detection Matters — overview of the programme and what to expect

Who should screen: Most guidelines recommend starting at age 45–50 for average-risk adults, with the FIT test (home stool test) every 1–2 years. Earlier screening applies if you have a family history, Lynch syndrome, or long-standing inflammatory bowel disease.

Prostate Cancer (PSA Testing)

Prostate-specific antigen (PSA) testing is more complex than most cancer screens. It can detect cancer early, but also leads to overdiagnosis and overtreatment of cancers that would never cause harm.

Prostate Cancer — Guide Hub — risk factors, the role of PSA, what an abnormal result means, and treatment decisions
PSA Screening: Benefits, Risks, and Shared Decision-Making — a balanced, evidence-based guide to what PSA measures, the decision framework, false positives, overdiagnosis, and navigating an elevated result

Who should screen: There is no universal programme for PSA screening. Most guidelines recommend an informed discussion between men aged 50–70 (or 45+ with elevated family risk or African heritage) and their clinician, weighing benefits and potential harms. PSA screening is not appropriate as a routine check without that conversation.

Skin Cancer

Skin cancer is among the most common cancers in Australia and other high UV-exposure countries. Most cases are preventable and treatable when caught early.

Skin Cancer — Warning Signs and Prevention — the ABCDE rule for melanoma, what to look for, and self-examination
Skin Cancer — Prevention — sun protection strategies

Who should screen: Australia has no national organised skin cancer screening program, but annual skin checks by a GP or dermatologist are recommended for people with a history of skin cancer, many moles, or significant past sun exposure.

Lung Cancer (Low-Dose CT Screening)

Lung cancer is the leading cause of cancer death globally and in Australia. Low-dose CT (LDCT) is the only screening method with demonstrated mortality reduction — but it is targeted at people with a significant smoking history, not the general population.

Lung Cancer Screening: Low-Dose CT, Benefits, Risks, and Eligibility — who qualifies, what pack-years means, the evidence from major trials, and shared decision-making

Who should screen: Adults with a 20 or more pack-year smoking history who currently smoke or have quit within the past 15 years, typically aged 50–80 (USPSTF 2021 criteria). Australia has no national lung cancer screening program as of 2026; discuss eligibility with your GP.

Heart and Metabolic Health

Cardiovascular and metabolic conditions are the leading causes of death globally — and many are detectable well before symptoms appear.

Blood Pressure

High blood pressure is the most common modifiable cardiovascular risk factor. It causes no symptoms until damage is already occurring.

High Blood Pressure (Hypertension): Symptoms, Causes, and Treatment — what the diagnosis means and treatment options
Blood Pressure at Home: How to Measure Correctly — accurate home monitoring technique and what to do with results

Who should check: All adults. Most guidelines recommend blood pressure checks every 1–2 years from age 18, or more frequently if readings are elevated or risk factors are present.

Cholesterol and Cardiovascular Risk

Standard cholesterol tests are a starting point — not the whole picture. Newer markers improve individual risk prediction.

Cardiovascular Risk Assessment: Beyond Cholesterol and Risk Scores — how risk is assessed today, and why CAC, ApoB, and Lp(a) are changing prevention
ApoB vs LDL Cholesterol: Which Matters More for Heart Risk? — why particle number may be more predictive than cholesterol levels
Lipoprotein(a): The Overlooked Genetic Heart Risk Factor — the genetic risk factor that standard tests miss
Preventing Heart Disease: Lifestyle and Medical Screening — practical steps and which tests to prioritise

Who should check: Cholesterol screening typically starts at age 35 in men and 45 in women (earlier if family history or other risk factors are present). Lp(a) testing is recommended at least once in life; a high result shifts risk management decisions.

Abdominal Aortic Aneurysm (AAA)

An abdominal aortic aneurysm is a dangerous, symptomless dilation of the main abdominal artery. Rupture is fatal in approximately 80–90% of cases. A single abdominal ultrasound can detect it before that happens.

Abdominal Aortic Aneurysm Screening: Who Should Be Tested and When — what an AAA is, why rupture is so dangerous, who should have an ultrasound, and how results guide surveillance and treatment

Who should screen: Men aged 65–75 who have ever smoked (USPSTF 2019 Grade B recommendation). Men aged 65 and over with a family history of AAA, or with established cardiovascular disease, should discuss screening with their GP. Australia has no national AAA screening program as of 2026.

Diabetes and Prediabetes

Type 2 diabetes develops slowly — prediabetes often precedes it by years and is entirely reversible with lifestyle change.

Prediabetes: Early Warning Signs and Prevention — who is at risk, what the blood tests show, and how reversal works
Type 2 Diabetes — diagnosis, management, and cardiometabolic risk
Understanding HbA1c — What It Means and How to Use It — interpreting the most common diabetes monitoring test

Who should screen: Adults over 40 with one or more risk factors (overweight, family history, gestational diabetes history, hypertension, or certain ethnicities with higher baseline risk). Screening uses fasting blood glucose or HbA1c.

Age-Based Health Checks

Screening needs change across the lifespan. This table summarises the most evidence-supported checks by decade.

In Your 20s

Cervical screening begins (typically age 25 in HPV-based programs)
Blood pressure check
Skin self-examination habits established
STI screening where relevant (STI Prevention Basics)

In Your 30s

Continue cervical screening
Blood pressure every 1–2 years
Cholesterol check if family history of early cardiovascular disease
Prediabetes risk discussion if overweight or other risk factors present

In Your 40s

Mammography discussion begins (many guidelines support from 40 with shared decision-making)
Cholesterol and cardiovascular risk assessment
Prediabetes/type 2 diabetes screening if risk factors present
Blood pressure annually
PSA discussion for men (earlier if high-risk family history or African heritage)
Skin check recommended if significant sun exposure history

In Your 50s

Mammography screening (most national programs start at 50)
Bowel cancer screening begins (FIT test from 45–50)
Bone density testing (DEXA) for women (earlier after early menopause or fracture)
Cardiovascular risk assessment — Lp(a) testing if not done
PSA discussion for men
Annual blood pressure and cholesterol

In Your 60s and Beyond

Continue all established screening (bowel, breast, cervical as appropriate)
Cardiovascular risk review — consider coronary artery calcium scoring
Bone density scan (DEXA) for women and high-risk men
Hearing and vision checks
Lung cancer screening (low-dose CT) for adults aged 50–80 with 20+ pack-year smoking history who currently smoke or quit within the past 15 years
Abdominal aortic aneurysm (AAA) ultrasound for men aged 65–75 who have ever smoked
Pneumococcal and shingles vaccination if not yet received

Women’s Health Screening

Women face specific screening requirements across the reproductive years, the menopausal transition, and beyond.

Cervical Cancer Screening Explained — HPV testing from age 25, self-collection options
Cervical Screening by Age — age-specific guidance
Mammography and Breast Cancer Screening — when to start, what results mean
Bone Density and Osteoporosis: What You Need to Know — bone loss accelerates at menopause; DXA scanning and prevention
Bone Density Testing (DEXA): Who Should Be Screened and When — how DEXA works, T-score interpretation, screening eligibility, and what to do after results
Menopause: Symptoms, Stages, and What to Expect — cardiovascular risk rises after menopause; prevention implications
Women’s Health Hub — centralised hub for all women’s health content

Men’s Health Screening

Men face underdiagnosis across many conditions — lower rates of healthcare engagement lead to later detection of cardiovascular disease, diabetes, and prostate cancer.

Prostate Cancer — Guide Hub — PSA testing, what a raised result means, and how to navigate the decision
PSA Screening: Benefits, Risks, and Shared Decision-Making — balanced guide to PSA testing, shared decision-making, and navigating an elevated result
Cardiovascular Risk Assessment — men have higher baseline cardiovascular risk and earlier onset of disease
Preventing Heart Disease — practical lifestyle and screening steps
Prediabetes — men with abdominal obesity have high metabolic risk; fasting glucose and HbA1c
Lung Cancer Screening (Low-Dose CT) — annual LDCT for men aged 50–80 with 20+ pack-year smoking history
Abdominal Aortic Aneurysm Screening — one-time ultrasound for men aged 65–75 who have ever smoked
Male Mental Health — mental health screening is part of preventive care; men are less likely to seek help unprompted

Preventive Health — Guide Hub — vaccination, nutrition, exercise, and broader lifestyle-based prevention
Testing and Screening — Guide Hub — how to interpret test results, sensitivity and specificity, cardiovascular biomarkers
Women’s Health Hub — cervical, breast, bone, and hormonal health
Cancer — Guide Hub — all cancer types, treatment, and survivorship
Heart & Circulation Hub — conditions, medications, and prevention
Diabetes Hub — type 1, type 2, prediabetes, and management

Last updated: June 2026

This hub is for educational purposes only and is not a substitute for professional medical advice. Screening recommendations vary by country, age, and individual risk. Speak with your clinician about which tests apply to you.